Highly Potent Active Pharmaceutical Ingredients 2017 (May, 22 - 23, 2017)
The global market for Highly Potent Active Pharmaceutical Ingredients is currently on a growth fast track, largely driven by its major use in oncology for cancer treatment and more often in the form of ADCs. Over a quarter of drugs worldwide now contain HPAPIs, as they have proven to be more effective than other APIs. However, working with APIs high in potency and cytotoxicity comes with many regulations and requirements, and presents pharmaceutical companies with challenges such as handling, containment, cost and security questions. This conference will cover many important and in-demand aspects of the HPAPI industry, creating a networking platform for industry professionals and key players to share their knowledge and find innovative new solutions.
More: http://www.smi-online.co.uk/pharmaceuticals/uk/Highly-Potent-Active-Ph
Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place.
ISSN 1802-2685
This website is maintained by: CREOS CZ
© 2006 - 2024 South Bohemian Agency for Support to Innovative Enterprising (JAIP)
Interesting biotechnology content:
Berkeley - University of California
Biotechnology portal - at Wikipedia. Useful information for you.
Researchers develop a novel dry-powder inhaled vaccine platform
Solar panels in your eyeballs: Self-powered bionics are on the way